Here are the highlights from the current issue:
The Wall Street Journal on Tuesday published a lengthy editorial attacking “Cheesecake Factory Medicine.” The breathtaking editorial is in response to a recent article in The New Yorker by Dr. Atul Gawande about efforts to combine quality control, cost control, and innovation.
http://tinyurl.com/chotw8v (subscription may be required)
An article in the August 27 issue of Newsweek discussed the high cost of new cancer therapies that offer limited benefits. According to the article, “Dr. Otis Brawley, chief medical and scientific officer of the American Cancer Society, says that in most cases, ‘new cancer treatments cost an awful lot of money, and there is usually a very small incremental benefit…Instead of talking about rationing care,’ Brawley says, ‘we need to talk about rational use of care.’”
A new web posting by Dr. Sally Rockey, NIH deputy director for extramural research, explores whether the number of applications submitted is correlated to more awards being received. Dr. Rockey writes, “It is evident from the data that, even within our top 100 funded organizations, institutions with similar averages of submitted applications per PI can have very different levels of success.”
The full list of announcements is below.